بدائل البحث:
treatment decreased » treatment increases (توسيع البحث)
significant step » significant sex (توسيع البحث), significant gap (توسيع البحث), significant group (توسيع البحث)
mean decrease » a decrease (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث), we decrease (توسيع البحث)
treatment decreased » treatment increases (توسيع البحث)
significant step » significant sex (توسيع البحث), significant gap (توسيع البحث), significant group (توسيع البحث)
mean decrease » a decrease (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث), we decrease (توسيع البحث)
-
121
-
122
-
123
-
124
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
منشور في 2025"…<b>(B-C)</b> Microscopic imaging confirmed the inhibition of colony formation in U87MG cells following SHG-44 treatment, with no colonies evident. <b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …"
-
125
-
126
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
127
-
128
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
منشور في 2025"…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …"
-
129
-
130
Summary of five key points guiding the Safe Steps evaluation and implementation.
منشور في 2025الموضوعات: -
131
-
132
-
133
Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.
منشور في 2025الموضوعات: -
134
-
135
Annual number of outpatient visits in recurrence and non-recurrence groups.
منشور في 2025الموضوعات: -
136
-
137
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
منشور في 2025الموضوعات: -
138
-
139
-
140
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: